![Illustration, die durch eine AI basierte Software erstellt wurde.](/system/files/styles/mdc_list_teaser_mdc_mobile_1_5x/private/2022-08/kaminski-nano-ai.jpg?h=436b82d4&itok=VKNOzr3Z)
CRISPR-based rapid tests for heart attacks & cancer
A CRISPR-based rapid test called CrisprZyme could help general practitioners to diagnose heart attacks and distinguish between different types of prostate cancer. They do not even need a lab, as an international team of scientists – including Michael Kaminski – reports in "Nature Nanotechnology".